(Q43031795)

12 November 2017

title

Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection (English)

1 reference

12 November 2017

1 reference

1 reference

Harcourt G

1 reference

12 November 2017

Hellier S

1 reference

12 November 2017

Bunce M

1 reference

12 November 2017

Satsangi J

1 reference

12 November 2017

Collier J

1 reference

12 November 2017

Chapman R

1 reference

12 November 2017

Phillips R

1 reference

12 November 2017

Klenerman P

1 reference

12 November 2017

publication date

1 May 2001

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

1 reference

12 November 2017

1 reference

12 November 2017

page(s)

174-179

1 reference

Immunological and virological predictors of outcome during interferon-alpha therapy of chronic hepatitis C.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Hepatitis C virus-specific CD4(+) T cells: do they help or damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

HLA association with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Interferon-alpha treatment induces delayed CD4 proliferative responses to the hepatitis C virus nonstructural protein 3 regardless of the outcome of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2001.00289.X

10.1046/J.1365-2893.2001.00289.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference